Lorlatinib in a Child with ALK -Fusion-Positive High-Grade Glioma.

Aditi Bagchi,Brent A. Orr,Olivia Campagne,Sandeep Kumar Dhanda,Sreenath Nair,Quynh T. Tran,Anthony M. Christensen,Amar Gajjar,Larissa V. Furtado,Aksana Vasilyeva,Frederick A. Boop,Clinton F. Stewart,Giles W. Robinson

Lorlatinib in a Child with ALK -Fusion-Positive High-Grade Glioma.

2021

Aditi Bagchi
Brent A. Orr
Olivia Campagne
Sandeep Kumar Dhanda
Sreenath Nair
Quynh T. Tran
Anthony M. Christensen
Amar Gajjar
Larissa V. Furtado
Aksana Vasilyeva
Frederick A. Boop
Clinton F. Stewart
Giles W. Robinson

Lorlatinib Response in ALK-Fusion–Positive Glioma A child near death with an ALK-fusion–positive high-grade glioma refractory to standard treatment had a dramatic response when treatment with lorla...

Keywords:

Glioma
Lorlatinib
Oncology
Internal medicine
Standard treatment
remission induction
severe acute respiratory syndrome coronavirus 2
Medicine
High-Grade Glioma
Refractory
2019 20 coronavirus outbreak

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations